P/E ratio for BB Biotech (BION.SW)
P/E ratio as of April 2024 (TTM): -2.83
According to BB Biotech 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -2.82578. At the end of 2016 the company had a P/E ratio of -3.83.
P/E ratio history for BB Biotech from 2009 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2016 | -3.83 | -175.99% |
| 2015 | 5.04 | 177.03% |
| 2014 | 1.82 | 5.63% |
| 2013 | 1.72 | -50.6% |
| 2012 | 3.49 | -109.84% |
| 2011 | -35.4 | 318.04% |
| 2010 | -8.48 | -110.49% |
| 2009 | 80.8 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.